Does MIPOMERSEN Cause Hepatic enzyme increased? 48 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Hepatic enzyme increased have been filed in association with MIPOMERSEN. This represents 24.1% of all adverse event reports for MIPOMERSEN.
48
Reports of Hepatic enzyme increased with MIPOMERSEN
24.1%
of all MIPOMERSEN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic enzyme increased From MIPOMERSEN?
Of the 48 reports, 5 (10.4%) required hospitalization.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIPOMERSEN. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does MIPOMERSEN Cause?
Injection site pain (67)
Injection site erythema (48)
Influenza like illness (36)
Injection site bruising (31)
Fatigue (26)
Nausea (24)
Injection site discolouration (23)
Injection site swelling (23)
Injection site rash (18)
Injection site reaction (17)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which MIPOMERSEN Alternatives Have Lower Hepatic enzyme increased Risk?
MIPOMERSEN vs MIRABEGRON
MIPOMERSEN vs MIRALAX
MIPOMERSEN vs MIRCERA
MIPOMERSEN vs MIRENA
MIPOMERSEN vs MIRIKIZUMAB-MRKZ